Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.53 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | HRH1 | P35367 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | TACR2 | P21452 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6207049 | 0.98 | IGF1R (0.57) | IGF1RALOX15CYP4A11CYP4F2CA2 | |
| SCHEMBL93545 | 0.98 | IGF1R (0.57) | IGF1RALOX15CYP4A11CYP4F2CA2 | |
| SCHEMBL12827576 | 0.98 | IGF1R (0.57) | IGF1RALOX15CYP4A11CYP4F2CA2 | |
| SCHEMBL11286656 | 0.98 | IGF1R (0.57) | IGF1RALOX15CYP4A11CYP4F2CA2 | |
| SCHEMBL9422698 | 0.98 | IGF1R (0.57) | IGF1RALOX15CYP4A11CYP4F2CA2 | |
| P-Xylene SCHEMBL6429103 | 0.98 | IGF1R (0.57) | IGF1RALOX15CYP4A11CYP4F2CA2 | |
| Methyl Alcohol SCHEMBL9951500 | 0.96 | IGF1R (0.55) | IGF1RALOX15CYP4A11CYP4F2CA2 | |
| SCHEMBL80441 | 0.93 | IGF1R (0.55) | IGF1RALOX15CYP4A11CYP4F2CA2 | |
| Toluene SCHEMBL7575476 | 0.92 | IGF1R (0.52) | IGF1RALOX15CYP4A11CYP4F2CA2 | |
| SCHEMBL6546754 | 0.87 | IGF1R (0.64) | IGF1RALOX15CYP1A2CYP2A6TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 460 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250275917-A1 | TOPICAL FOAMABLE PHARMACEUTICAL COMPOSITION | EUROFARMA LABORATORIOS S.A. (BR) | 2025-09-04 | — | — | US | claimed |
| CN-113049685-B | Quality detection method of compound radix zanthoxyli lozenge | 广西壮族自治区花红药业股份有限公司 | 2024-07-30 | — | — | CN | claimed |
| EP-4282418-A9 | FOAMING TOPICAL PHARMACEUTICAL COMPOSITION | Eurofarma Laboratórios S.A. (BR) | 2024-07-17 | — | — | EP | claimed |
| EP-4282418-A1 | FOAMING TOPICAL PHARMACEUTICAL COMPOSITION | Eurofarma Laboratórios S.A. (BR) | 2023-11-29 | — | — | EP | claimed |
| CN-116283726-A | Preparation method and application of cyanine dye variant and cyanine protein composite fluorophore | 吉林大学第一医院 | 2023-06-23 | — | — | CN | claimed |
| CN-113248940-B | Heptamethine cyanine dye with high-selectivity red light absorption, and synthesis method and application thereof | 上海戎科特种装备有限公司 | 2023-02-17 | — | — | CN | claimed |
| WO-2022178604-A1 | FOAMING TOPICAL PHARMACEUTICAL COMPOSITION | EUROFARMA LABORATORIOS S.A. (BR) | 2022-09-01 | — | — | WO | claimed |
| CN-113683602-B | Heptamethine cyanine micromolecule for multi-modal treatment of hypoxic tumors, and preparation method and application thereof | 中国人民解放军陆军军医大学 | 2022-06-10 | — | — | CN | claimed |
| CN-113683602-A | Heptamethine cyanine small molecule for multi-modal treatment of hypoxic tumors, and preparation method and application thereof | 中国人民解放军陆军军医大学 | 2021-11-23 | — | — | CN | claimed |
| CN-108084325-B | Preparation of acrylic resin and application of acrylic resin in antifouling paint | 浙江海洋大学 | 2021-03-30 | — | — | CN | claimed |
| US-20060083706-A1 | Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant | L'OREAL S.A. (FR) | 2006-04-20 | — | — | US | claimed |
| US-20060078523-A1 | Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair | L'OREAL S.A. (FR) | 2006-04-13 | — | — | US | claimed |
| US-20060078522-A1 | Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt | L'OREAL S.A. (FR) | 2006-04-13 | — | — | US | claimed |
| US-20030175229-A1 | Electrophilic monomers for treating the hair | L'OREAL (FR) | 2003-09-18 | — | — | US | claimed |
| US-5700468-A | CONSISTS OF GINKGO FLAVONE GLUCOSIDES, PROANTHOCYANIDINES, GINKGOLIDES, BILOBALIDE, AND SULFURIC ASH; FREE OF ALKYL PHENOL; USEFUL FOR TREATING VASCULAR SYSTEM DISORDER | INDENA SPA (IT) | 1997-12-23 | — | — | US | claimed |
| US-5637302-A | SOLVENT EXTRACTION FROM LEAVES | INDENA SPA (IT) | 1997-06-10 | — | — | US | claimed |
| EP-0360556-B1 | NEW EXTRACTS OF GINKGO BILOBA AND THEIR METHODS OF PREPARATION | INDENA S.p.A. (IT) | 1993-04-21 | — | — | EP | claimed |
| EP-0360556-A1 | New extracts of ginkgo biloba and their methods of preparation | INDENA S.p.A. (IT) | 1990-03-28 | — | — | EP | claimed |
| EP-0225785-A2 | Preparation of mono-disperse metal oxides | AKZO N.V. (NL) | 1987-06-16 | — | — | EP | claimed |
| US-4204987-A | Aqueous polyester dispersion for adhering vinyl film to wood | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1980-05-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030175229-A1 | Electrophilic monomers for treating the hair | NACA, SUCLG1, TYR | IGF1R 4818/4885ALOX15 677/4885CYP4A11 2989/4885 |
| US-20060083706-A1 | Haircare composition comprising at least one electrophilic monomer and micro- or nanoparticles of at least one solid lubricant | MITF, CUTA, NACA | IGF1R 3089/4885ALOX15 3511/4885CYP4A11 4744/4885 |
| US-20060078523-A1 | Composition comprising at least one electrophilic monomer and at least one acid in a cosmetically acceptable anhydrous medium, and use thereof for cosmetic treatment of the hair | HOGA1, OAT, SUCLG1 | IGF1R 4356/4885ALOX15 467/4885CYP4A11 3077/4885 |
| US-20060078522-A1 | Composition for treating keratin materials comprising at least one electrophilic monomer and at least one salt | KRT18, DSG1, DSC1 | IGF1R 4451/4885ALOX15 3822/4885CYP4A11 4278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.